Notizie dei mercati

CASI Pharmaceuticals, Inc.: BTIG mantiene la raccomandazione Buy

This content has been archived. It may no longer be relevant

CASI Pharmaceuticals, Inc.: BTIG mantiene la raccomandazione Buy

Pharmaceuticals mantiene raccomandazione


FIMA2681# 2022-08-15T17:01:16+02:00

Show More